Skip to main content
SpringerLink
Log in

Role of Imaging in Detecting Bowel Fibrosis and Bowel Damage

  • Chapter
  • First Online:
Cross-Sectional Imaging in Crohn’s Disease

  • 512 Accesses

Abstract

Imaging plays a key role in the comprehensive assessment of bowel structural damage. Radiology is fundamental to confirm the initial diagnosis and the extent of disease along the digestive tract. Moreover, imaging is a critical tool in the monitoring of the response to drug therapy. In this chapter, technique, indications and limitations of the major imaging methods used in the assessment of CD (ultrasound, computed tomography, magnetic resonance imaging) are reviewed. A special focus is dedicated to the detection and quantification of bowel fibrosis and bowel wall damage with CT and MRI. Future perspectives are finally reviewed according to the latest developments in imaging technology.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Freeman HJ. Natural history and clinical behavior of Crohn’s disease extending beyond two decades. J Clin Gastroenterol. 2003;37:216–9.

    Article  Google Scholar 

  2. Sasaki T, Kunisaki R, Kinoshita H, et al. Doppler ultrasound findings correlate with tissue vascularity and inflammation in surgical pathology specimens from patients with small intestinal Crohn’s disease. BMC Res Notes. 2014;7:363.

    Article  Google Scholar 

  3. Dignass A, Van Assche G, Lindsay JO, et al. The second European evidence-based consensus on the diagnosis and management of Crohn’s disease: current management. J Crohns Colitis. 2010;4:28–62.

    Article  CAS  Google Scholar 

  4. Yamamoto T. Factors affecting recurrence after surgery for Crohn’s disease. World J Gastroenterol. 2005;11:3971–9.

    Article  Google Scholar 

  5. Peyrin-Biroulet L, Cieza A, Sandborn WJ, et al. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut. 2012;61:241–7.

    Article  Google Scholar 

  6. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn’s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6:8–15.

    Article  CAS  Google Scholar 

  7. Louis E, Collard A, Oger AF, et al. Behaviour of Crohn’s disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001;49:777–82.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis. 2002;8:244–50.

    Article  Google Scholar 

  9. Molenaar ETH, Voskuyl AE, Dinant HJ, et al. Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum. 2004;50:36–42.

    Article  Google Scholar 

  10. Danese S, Fiorino G, Peyrin-Biroulet L. Early intervention in Crohn’s disease: towards disease modification trials. Gut. 2017;66:2179–87.

    Article  CAS  Google Scholar 

  11. Ordás I, Rimola J, Rodríguez S, et al. Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn’s disease. Gastroenterology. 2014;146:374–82.e1.

    Article  Google Scholar 

  12. Fiorino G, Bonifacio C, Allocca M, et al. Bowel damage as assessed by the Lémann index is reversible on anti-TNF therapy for Crohn’s disease. J Crohns Colitis. 2015;9:633–9.

    Article  Google Scholar 

  13. Bodini G, Giannini EG, De Maria C, et al. Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn’s disease. A study performed using the Lémann index. Dig Liver Dis. 2017;49:175–80.

    Article  CAS  Google Scholar 

  14. Fiorino G, Morin M, Bonovas S, et al. Prevalence of bowel damage assessed by cross-sectional imaging in early Crohn’s disease and its impact on disease outcome. J Crohns Colitis. 2017;11:274–80.

    Article  Google Scholar 

  15. Peyrin-Biroulet L, Loftus EV, Colombel J-F, et al. Early Crohn disease: a proposed definition for use in disease-modification trials. Gut. 2010;59:141–7.

    Article  CAS  Google Scholar 

  16. Fiorino G, Bonifacio C, Peyrin-Biroulet L, et al. Preventing collateral damage in Crohn’s disease: the Lémann index. J Crohns Colitis. 2016;10:495–500.

    Article  Google Scholar 

  17. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(Suppl A):5A–36A.

    Article  Google Scholar 

  18. Vester-Andersen MK, Prosberg MV, Jess T, et al. Disease course and surgery rates in inflammatory bowel disease: a population-based, 7-year follow-up study in the era of immunomodulating therapy. Am J Gastroenterol. 2014;109:705–14.

    Article  Google Scholar 

  19. Panés J, Bouzas R, Chaparro M, et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease. Aliment Pharmacol Ther. 2011;34:125–45.

    Article  Google Scholar 

  20. Pariente B, Peyrin-Biroulet L, Cohen L, et al. Gastroenterology review and perspective: the role of cross-sectional imaging in evaluating bowel damage in Crohn disease. AJR Am J Roentgenol. 2011;197:42–9.

    Article  Google Scholar 

  21. Fiorino G, Bonifacio C, Peyrin-Biroulet L, et al. Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn’s disease. Inflamm Bowel Dis. 2011;17:1073–80.

    Article  CAS  Google Scholar 

  22. Daperno M, D’Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest Endosc. 2004;60:505–12.

    Article  Google Scholar 

  23. Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn’s disease: a prospective multicentre study. Groupe d’Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut. 1989;30:983–9.

    Article  CAS  Google Scholar 

  24. Pariente B, Mary J-Y, Danese S, et al. Development of the Lémann index to assess digestive tract damage in patients with Crohn’s disease. Gastroenterology. 2015;148:52–63.e3.

    Article  Google Scholar 

  25. Rimola J, Rodriguez S, García-Bosch O, et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut. 2009;58:1113–20.

    Article  CAS  Google Scholar 

  26. Eder P, Michalak M, Katulska K, et al. Magnetic resonance enterographic predictors of one-year outcome in ileal and ileocolonic Crohn’s disease treated with anti-tumor necrosis factor antibodies. Sci Rep. 2015;5:10223.

    Article  Google Scholar 

  27. Tielbeek JAW, Ziech MLW, Li Z, et al. Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn’s disease assessment with histopathology of surgical specimens. Eur Radiol. 2014;24:619–29.

    Article  Google Scholar 

  28. Punwani S, Rodriguez-Justo M, Bainbridge A, et al. Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features. Radiology. 2009;252:712–20.

    Article  Google Scholar 

  29. Zappa M, Stefanescu C, Cazals-Hatem D, et al. Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn’s disease? A retrospective comparison with surgical pathologic analysis. Inflamm Bowel Dis. 2011;17:984–93.

    Article  Google Scholar 

  30. Adler J, Punglia DR, Dillman JR, et al. Computed tomography enterography findings correlate with tissue inflammation, not fibrosis in resected small bowel Crohn’s disease. Inflamm Bowel Dis. 2012;18:849–56.

    Article  Google Scholar 

  31. Rieder F, Fiocchi C. Intestinal fibrosis in IBD—a dynamic, multifactorial process. Nat Rev Gastroenterol Hepatol. 2009;6:228–35.

    Article  CAS  Google Scholar 

  32. Lenze F, Wessling J, Bremer J, et al. Detection and differentiation of inflammatory versus fibromatous Crohn’s disease strictures: prospective comparison of 18F-FDG-PET/CT, MR-enteroclysis, and transabdominal ultrasound versus endoscopic/histologic evaluation. Inflamm Bowel Dis. 2012;18:2252–60.

    Article  Google Scholar 

  33. Latella G, Sferra R, Speca S, et al. Can we prevent, reduce or reverse intestinal fibrosis in IBD? Eur Rev Med Pharmacol Sci. 2013;17:1283–304.

    CAS  PubMed  Google Scholar 

  34. Lahat A, Chowers Y. The patient with recurrent (sub) obstruction due to Crohn’s disease. Best Pract Res Clin Gastroenterol. 2007;21:427–44.

    Article  Google Scholar 

  35. Van Assche G, Geboes K, Rutgeerts P. Medical therapy for Crohn’s disease strictures. Inflamm Bowel Dis. 2004;10:55–60.

    Article  Google Scholar 

  36. Ram R, Sarver D, Pandey T, et al. Magnetic resonance enterography: a stepwise interpretation approach and role of imaging in management of adult Crohn’s disease. Indian J Radiol Imaging. 2016;26:173–84.

    Article  Google Scholar 

  37. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749–53.

    Article  CAS  Google Scholar 

  38. Fiorino G, Bonifacio C, Malesci A, et al. MRI in Crohn’s disease—current and future clinical applications. Nat Rev Gastroenterol Hepatol. 2011;9:23–31.

    Article  Google Scholar 

  39. Rimola J, Planell N, Rodríguez S, et al. Characterization of inflammation and fibrosis in Crohn’s disease lesions by magnetic resonance imaging. Am J Gastroenterol. 2015;110:432–40.

    Article  Google Scholar 

  40. Ripollés T, Rausell N, Paredes JM, et al. Effectiveness of contrast-enhanced ultrasound for characterisation of intestinal inflammation in Crohn’s disease: a comparison with surgical histopathology analysis. J Crohns Colitis. 2013;7:120–8.

    Article  Google Scholar 

  41. Wilkens R, Peters DA, Nielsen AH, et al. Dynamic contrast-enhanced magnetic resonance enterography and dynamic contrast-enhanced ultrasonography in Crohn’s disease: an observational comparison study. Ultrasound Int Open. 2017;3:E13–24.

    Article  Google Scholar 

  42. Morimoto K, Watanabe K, Noguchi A, et al. Clinical impact of ultrathin colonoscopy for Crohn’s disease patients with strictures. J Gastroenterol Hepatol. 2015;30(Suppl 1):66–70.

    Article  Google Scholar 

  43. Fraquelli M, Branchi F, Cribiù FM, et al. The role of ultrasound elasticity imaging in predicting ileal fibrosis in Crohn’s disease patients. Inflamm Bowel Dis. 2015;21:2605–12.

    Article  Google Scholar 

  44. Dillman JR, Stidham RW, Higgins PDR, et al. Ultrasound shear wave elastography helps discriminate low-grade from high-grade bowel wall fibrosis in ex vivo human intestinal specimens. J Ultrasound Med. 2014;33:2115–23.

    Article  Google Scholar 

  45. Calabrese E, Zorzi F, Zuzzi S, et al. Development of a numerical index quantitating small bowel damage as detected by ultrasonography in Crohn’s disease. J Crohns Colitis. 2012;6:852–60.

    Article  Google Scholar 

  46. Calabrese E, Zorzi F, Pallone F. Ultrasound of the small bowel in Crohn’s disease. Int J Inflam. 2012;2012:964720.

    Article  Google Scholar 

  47. Peng JC, Feng Q, Zhu J, et al. Usefulness of spectral computed tomography for evaluation of intestinal activity and severity in ileocolonic Crohn’s disease. Therap Adv Gastroenterol. 2016;9:795–805.

    Article  Google Scholar 

  48. Panes J, Bouhnik Y, Reinisch W, et al. Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines. J Crohns Colitis. 2013;7:556–85.

    Article  CAS  Google Scholar 

  49. Haas K, Rubesova E, Bass D. Role of imaging in the evaluation of inflammatory bowel disease: how much is too much? World J Radiol. 2016;8:124–31.

    Article  Google Scholar 

  50. Holtmann MH, Uenzen M, Helisch A, et al. 18F-Fluorodeoxyglucose positron-emission tomography (PET) can be used to assess inflammation non-invasively in Crohn’s disease. Dig Dis Sci. 2012;57:2658–68.

    Article  Google Scholar 

  51. Catalano OA, et al. Evaluation of quantitative PET/MR enterography biomarkers for discrimination of inflammatory strictures from fibrotic strictures in crohn disease. Radiology. 2016;278:792–800. https://doi.org/10.1148/radiol.2015150566.

    Article  Google Scholar 

  52. Stanley E, Moriarty HK, Cronin CG. Advanced multimodality imaging of inflammatory bowel disease in 2015: an update. World J Radiol. 2016;8:571–80.

    Article  Google Scholar 

  53. Giannetti A, Matergi M, Biscontri M, et al. Real-time elastography in Crohn’s disease: feasibility in daily clinical practice. J Ultrasound. 2017;20:147–55.

    Article  Google Scholar 

  54. Buisson A, Pereira B, Goutte M, et al. Magnetic resonance index of activity (MaRIA) and Clermont score are highly and equally effective MRI indices in detecting mucosal healing in Crohn’s disease. Dig Liver Dis. 2017;49:1211–7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Humanitas Research Hospital, Via Alessandro Manzoni 56, Milan, Italy

    Cristiana Bonifacio

  2. Department of Radiology, Humanitas Research Hospital, Humanitas University, Training School in Radiology, Via Rita Levi Montalcini 4, Milan, Italy

    Nicolò Gennaro

  3. IBD Center, Department of Gastroenterology, Humanitas Research Hospital, Via Alessandro Manzoni 56, Milan, Italy

    Gionata Fiorino

  4. Department of Biomedical Sciences, Humanitas University, Via Alessandro Manzoni 56, Milan, Italy

    Gionata Fiorino

Authors
  1. Cristiana Bonifacio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nicolò Gennaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gionata Fiorino
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cristiana Bonifacio .

Editor information

Editors and Affiliations

  1. Department of Radiology, Hospital Clínic of Barcelona, CIBEREHD, University of Barcelona, Barcelona, Spain

    Jordi Rimola

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bonifacio, C., Gennaro, N., Fiorino, G. (2019). Role of Imaging in Detecting Bowel Fibrosis and Bowel Damage. In: Rimola, J. (eds) Cross-Sectional Imaging in Crohn’s Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-96586-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-96586-4_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-96585-7

  • Online ISBN: 978-3-319-96586-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation